Affiliation
Laser Oncology Programme, Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.Issue Date
1997-05
Metadata
Show full item recordAbstract
The subcellular, cellular and tissue/tumour interactions with non-toxic photosensitizing chemicals plus non-thermal visible light (photodynamic therapy (PDT) are reviewed. The extent to which endothelium/vasculature is the primary target is discussed, and the biochemical opportunities for manipulating outcome highlighted. The nature of tumour destruction by PDT lends itself to imaging outcome by MRI and PET.Citation
The biology of photodynamic therapy. 1997, 42 (5):913-35 Phys Med BiolJournal
Physics in Medicine and BiologyDOI
10.1088/0031-9155/42/5/012PubMed ID
9172267Type
ArticleLanguage
enISSN
0031-9155ae974a485f413a2113503eed53cd6c53
10.1088/0031-9155/42/5/012
Scopus Count
Collections
Related articles
- Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.
- Authors: Kübler AC, Stenzel W, Rühling M, Meul B, Fischer JH
- Issue date: 2003
- Vascular effects of photodynamic therapy.
- Authors: Krammer B
- Issue date: 2001 Nov-Dec
- Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction.
- Authors: Fingar VH, Wieman TJ, Doak KW
- Issue date: 1990 May 1
- Nuclear medicine for photodynamic therapy in cancer: Planning, monitoring and nuclear PDT.
- Authors: Kharroubi Lakouas D, Huglo D, Mordon S, Vermandel M
- Issue date: 2017 Jun
- Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitization.
- Authors: Chatlani PT, Nuutinen PJ, Toda N, Barr H, MacRobert AJ, Bedwell J, Bown SG
- Issue date: 1992 Aug